The program will include scientific talks, poster presentations, exhibitions for organizations, a welcome reception, and a conference dinner. Together, let’s pave the way for improving the lives of ...

The first event is the BIO CEO & Investor Conference in New York on February 10, 2025, where Skye will discuss obesity treatment innovations. The second event is the Oppenheimer 35th Healthcare ...

Amgen has reported that its once-monthly dosing regimen and manufacturing capabilities will be key to entering the obesity market. Presenting at the JP Morgan Healthcare Conference 2025 on 13 ...

The conference is scheduled between 13 January and 16 January. Obesity is expected to remain a major focus for the industry. The sector’s focus on the below advancements highlights the growing ...